Heparin-Induced Thrombocytopenia and Antiphospholipid Syndrome are easy to mix up on the boards. Here's a side-by-side comparison — presentation, workup, imaging, and first-line treatment — drawn from our full outlines.
Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome at a glance
Heparin-Induced Thrombocytopenia: Antibody-mediated platelet activation by heparin-PF4 complexes causing paradoxical thrombosis with thrombocytopenia.
Antiphospholipid Syndrome: Autoimmune disorder with antiphospholipid antibodies causing arterial/venous thrombosis and pregnancy morbidity.
Try two board-style questions on Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome
Real questions from the FirstPassPA bank, with the full explanation. Pick an answer — no signup, no email.
Question 1HematologyMedium
A 69-year-old man has a platelet count fall from 240,000/µL to 85,000/µL five days after cardiac surgery requiring bypass. He develops a painful swollen leg. Which of the following is the strongest risk factor for this syndrome?
AUse of low-molecular-weight heparin
BUse of fondaparinux for prophylaxis
CUse of unfractionated heparin
DUse of warfarin for prophylaxis
Reveal answer & full explanation
Correct answer: C — Use of unfractionated heparin
AUse of low-molecular-weight heparin
BUse of fondaparinux for prophylaxis
CUse of unfractionated heparin✓
DUse of warfarin for prophylaxis
Why Use of unfractionated heparin is correct
Heparin-induced thrombocytopenia is driven by antibodies to platelet factor 4-heparin complexes, and unfractionated heparin binds PF4 far more avidly than other agents, giving it the highest HIT risk.
The post-cardiac-surgery setting compounds risk, as bypass exposes patients to high-dose UFH and the highest PF4 antibody seroconversion rates.
A 50% platelet drop at day 5 with new limb thrombosis is the classic timing and thrombotic phenotype of HIT.
Why the others are wrong
Use of low-molecular-weight heparin — Right-drug-class wrong-magnitude trap: LMWH can cause HIT but at roughly one-tenth the rate of UFH, so it is not the strongest risk factor.
Use of fondaparinux for prophylaxis — Buzzword-reversal trap: fondaparinux essentially does not form immunogenic PF4 complexes and is actually used to treat HIT, not cause it.
Use of warfarin for prophylaxis — Anchoring trap: warfarin causes no PF4 immune reaction, and starting it during acute HIT risks warfarin-induced limb gangrene.
Question 2HematologyMedium
A 38-year-old woman presents with recurrent deep vein thromboses (DVTs) and a spontaneous miscarriage at 14 weeks. She has livedo reticularis on exam. Labs show prolonged PTT that does not correct with mixing study. Anti-cardiolipin IgG and lupus anticoagulant are positive on two separate occasions 12 weeks apart. What is the most likely diagnosis?
AHeparin-induced thrombocytopenia
BFactor V Leiden
CAntiphospholipid syndrome
DProtein C deficiency
Reveal answer & full explanation
Correct answer: C — Antiphospholipid syndrome
AHeparin-induced thrombocytopenia
BFactor V Leiden
CAntiphospholipid syndrome✓
DProtein C deficiency
Why Antiphospholipid syndrome is correct
Antiphospholipid syndrome (APS) requires clinical criteria (thrombosis or pregnancy morbidity) plus lab criteria (positive antiphospholipid antibodies on two occasions 12 weeks apart: lupus anticoagulant, anti-cardiolipin IgG/IgM, or anti-beta2-glycoprotein-I)
This patient meets both: recurrent DVTs and spontaneous miscarriage at 14 weeks (clinical); positive anti-cardiolipin IgG and lupus anticoagulant on two separate occasions 12 weeks apart (lab)
Prolonged PTT that does not correct with mixing (inhibitor pattern) is characteristic of lupus anticoagulant
Why the others are wrong
Heparin-induced thrombocytopenia — HIT causes thrombocytopenia and thrombosis but requires prior heparin exposure; no heparin exposure is mentioned, and it does not explain the positive antiphospholipid antibodies or prolonged PTT inhibitor pattern
Factor V Leiden — causes thrombophilia but does not explain prolonged PTT with inhibitor pattern, positive antiphospholipid antibodies, or pregnancy loss in this pattern
Protein C deficiency — causes thrombophilia but would not cause a prolonged PTT that fails to correct with mixing, nor positive antiphospholipid antibodies
Additional high-yield points
Treatment: warfarin (target INR 2-3 for venous thrombosis; INR 3-4 for recurrent or arterial thrombosis)
Direct oral anticoagulants (DOACs) are not preferred in APS — rivaroxaban was inferior to warfarin (more thrombotic events) in triple-positive APS in the TRAPS trial
🔒 Free preview limit reached
Keep comparing — start your free trial
You've used your 2 free previews. Create your free account to see the full Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome comparison — plus all 514 diagnosis outlines, 7,200+ board-style questions, and an AI tutor. Your 7-day free trial includes everything, no credit card required.
Antibody-mediated platelet activation by heparin-PF4 complexes causing paradoxical thrombosis with thrombocytopenia.
Autoimmune disorder with antiphospholipid antibodies causing arterial/venous thrombosis and pregnancy morbidity.
Classic presentation
Platelet count fall 5-10 days after starting heparin with new thrombosis — the 'paradoxical' picture of thrombocytopenia with clotting rather than bleeding.; Often asymptomatic platelet drop noticed on routine CBC 5-10 days after starting heparin; Rapid-onset HIT (within hours) in patients with heparin exposure within prior 100 days;…
Young patient with unprovoked venous or arterial thrombosis (DVT, PE, stroke) and/or recurrent pregnancy loss, often with livedo reticularis, mild thrombocytopenia, and a prolonged aPTT that does not correct on mixing study; antiphospholipid antibodies persist on repeat testing ≥12 weeks apart. Catastrophic APS is the rare variant:…
Workup / key labs
4Ts score 0-3 (low) → HIT unlikely; 4-5 (intermediate) and 6-8 (high) → stop heparin, start non-heparin anticoagulant, send PF4 ELISA and confirmatory functional assay. Diagnosis = clinical probability + positive functional assay.; Calculate 4Ts score: Thrombocytopenia, Timing, Thrombosis, oTher causes (each 0-2 points);…
Revised Sapporo (Sydney) criteria — requires ≥1 clinical criterion (vascular thrombosis or pregnancy morbidity) AND ≥1 laboratory criterion (LA, anti-cardiolipin, or anti-β2GP1) on two occasions at least 12 weeks apart. The 2023 ACR/EULAR classification criteria require an entry criterion (a positive aPL test within 3 years of an…
Imaging
Lower extremity venous duplex Doppler in all patients diagnosed with HIT; CT/CTA or other vascular imaging guided by clinical signs of thrombosis; CT abdomen if adrenal hemorrhage suspected
Duplex US, CTPA, MRI brain as clinically indicated by symptoms; Echocardiogram to evaluate for Libman-Sacks endocarditis
First-line treatment
STOP all heparin immediately (including flushes, LMWH, heparin-coated catheters); Start non-heparin anticoagulant at therapeutic dose — argatroban (direct thrombin inhibitor, hepatic clearance) or bivalirudin (DTI, predominantly enzymatic/proteolytic clearance with minor renal component) for inpatients; fondaparinux or a DOAC is an…
Acute thrombosis — therapeutic anticoagulation: unfractionated heparin or LMWH bridge to warfarin (INR 2-3); Long-term venous thrombosis — warfarin INR 2-3 indefinitely; Long-term arterial thrombosis or recurrent venous thrombosis on warfarin — warfarin INR 3-4, or warfarin + low-dose aspirin; DOACs (rivaroxaban, apixaban) are INFERIOR…
Drill Heparin-Induced Thrombocytopenia vs Antiphospholipid Syndrome questions on FirstPassPA
Turn this comparison into retention. 7,200+ board-style questions with an AI tutor that explains every answer — free to start, no card required.
Educational use only. This outline is a study aid for PA students and is not medical advice or a substitute for clinical judgment. FirstPassPA is an independent study tool and is not affiliated with, endorsed by, or sponsored by NCCPA or PAEA. PANCE® and PANRE® are registered trademarks of the National Commission on Certification of Physician Assistants; End of Rotation™ is a program of the Physician Assistant Education Association.